Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01379716 · ClinicalTrials.gov registry record · NA

Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls

A NA study, sponsored by Albany Medical College.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01379716 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01379716, a NA study, has completed, sponsored by Albany Medical College.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Postherpetic Neuralgia is a painful nerve condition that can occur when nerve fibers are damaged following an outbreak of shingles. The purpose of this study is to identify and study abnormalities in the nerves and cells in the of patients with postherpetic Neuralgia (PHN) and characterize changes that could be responsible for causing nerve pain. This data will be compared to the tissue of healthy volunteers. Our goal is that this information will lead to the development of better treatment options for people with painful nerve conditions.

Interventions

  • OTHER skin biopsy

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2011-01
Est. Completion 2013-06
Phase NA

Sponsor

Albany Medical College

52 total trials

What the Registry Record Tells You About NCT01379716

The ClinicalTrials.gov registry entry for NCT01379716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which skin biopsy is the first listed.

NCT01379716 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01379716 about?

NCT01379716 is a clinical study titled "Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls". Postherpetic Neuralgia is a painful nerve condition that can occur when nerve fibers are damaged following an outbreak of shingles. The purpose of this study is to identify and study abnormalities in the nerves and cells in the of patients with postherpetic Neuralgia (PHN) and characterize changes ...

What is the current status of trial NCT01379716?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-01. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01379716?

The interventions under investigation include: skin biopsy (OTHER).

Who is sponsoring clinical trial NCT01379716?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.